The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Non-opioid Pain Patch Market Outlook 2024

Global Non-opioid Pain Patch Market Outlook 2024

Publishing Date : Dec, 2021

License Type :
 

Report Code : 1634970

No of Pages : 126

Ask Your Query

Synopsis
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

The global Non-opioid Pain Patch market was valued at US$ 631.4 million in 2020 and is expected to reach US$ 779.5 million by the end of 2027, growing at a CAGR of 2.6% during 2021-2027.

This report focuses on Non-opioid Pain Patch volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Non-opioid Pain Patch market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Non-opioid Pain Patch Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Lidocaine Patches
  • Diclofenac Patches
  • Indomethacin Patches
  • Counter-Irritant Patches
  • Fentanyl Patches
  • Others

Segment by Application

  • OTC
  • Rx

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Hisamitsu
  • Mylan
  • Johnson & Johnson
  • Actavis
  • Lingrui
  • Teikoku Seiyaku
  • Sanofi
  • Novartis
  • Qizheng
  • Endo
  • Huarun 999
  • GSK
  • Haw Par
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier
  • Blue-Emu

Scope of the Non-opioid Pain Patch Market Report

Report Metric

Details

Report Name

Non-opioid Pain Patch Market

Market size in 2020

US$ 631.4 Million

The revenue forecast in 2027

US$ 779.5 Million

Growth Rate

CAGR of 2.6% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Non-opioid Pain Patch Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Patch
1.2 Non-opioid Pain Patch Segment by Type
1.2.1 Global Non-opioid Pain Patch Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Indomethacin Patches
1.2.5 Counter-Irritant Patches
1.2.6 Fentanyl Patches
1.2.7 Others
1.3 Non-opioid Pain Patch Segment by Application
1.3.1 Global Non-opioid Pain Patch Sales Comparison by Application: (2021-2027)
1.3.2 OTC
1.3.3 Rx
1.4 Global Non-opioid Pain Patch Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patch Revenue 2016-2027
1.4.2 Global Non-opioid Pain Patch Sales 2016-2027
1.4.3 Non-opioid Pain Patch Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-opioid Pain Patch Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2016-2021)
2.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Non-opioid Pain Patch Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Non-opioid Pain Patch Manufacturing Sites, Area Served, Product Type
2.5 Non-opioid Pain Patch Market Competitive Situation and Trends
2.5.1 Non-opioid Pain Patch Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Patch Players Market Share by Revenue
2.5.3 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-opioid Pain Patch Retrospective Market Scenario by Region
3.1 Global Non-opioid Pain Patch Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Non-opioid Pain Patch Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Non-opioid Pain Patch Market Facts & Figures by Country
3.3.1 North America Non-opioid Pain Patch Sales by Country
3.3.2 North America Non-opioid Pain Patch Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-opioid Pain Patch Market Facts & Figures by Country
3.4.1 Europe Non-opioid Pain Patch Sales by Country
3.4.2 Europe Non-opioid Pain Patch Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Region
3.5.1 Asia Pacific Non-opioid Pain Patch Sales by Region
3.5.2 Asia Pacific Non-opioid Pain Patch Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-opioid Pain Patch Market Facts & Figures by Country
3.6.1 Latin America Non-opioid Pain Patch Sales by Country
3.6.2 Latin America Non-opioid Pain Patch Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-opioid Pain Patch Sales by Country
3.7.2 Middle East and Africa Non-opioid Pain Patch Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-opioid Pain Patch Historic Market Analysis by Type
4.1 Global Non-opioid Pain Patch Sales Market Share by Type (2016-2021)
4.2 Global Non-opioid Pain Patch Revenue Market Share by Type (2016-2021)
4.3 Global Non-opioid Pain Patch Price by Type (2016-2021)

5 Global Non-opioid Pain Patch Historic Market Analysis by Application
5.1 Global Non-opioid Pain Patch Sales Market Share by Application (2016-2021)
5.2 Global Non-opioid Pain Patch Revenue Market Share by Application (2016-2021)
5.3 Global Non-opioid Pain Patch Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Corporation Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Mylan Non-opioid Pain Patch Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Corporation Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Actavis Non-opioid Pain Patch Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Lingrui
6.5.1 Lingrui Corporation Information
6.5.2 Lingrui Description and Business Overview
6.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lingrui Non-opioid Pain Patch Product Portfolio
6.5.5 Lingrui Recent Developments/Updates
6.6 Teikoku Seiyaku
6.6.1 Teikoku Seiyaku Corporation Information
6.6.2 Teikoku Seiyaku Description and Business Overview
6.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
6.6.5 Teikoku Seiyaku Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Non-opioid Pain Patch Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Novartis Non-opioid Pain Patch Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Qizheng
6.9.1 Qizheng Corporation Information
6.9.2 Qizheng Description and Business Overview
6.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Qizheng Non-opioid Pain Patch Product Portfolio
6.9.5 Qizheng Recent Developments/Updates
6.10 Endo
6.10.1 Endo Corporation Information
6.10.2 Endo Description and Business Overview
6.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Endo Non-opioid Pain Patch Product Portfolio
6.10.5 Endo Recent Developments/Updates
6.11 Huarun 999
6.11.1 Huarun 999 Corporation Information
6.11.2 Huarun 999 Non-opioid Pain Patch Description and Business Overview
6.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
6.11.5 Huarun 999 Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Non-opioid Pain Patch Description and Business Overview
6.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.12.4 GSK Non-opioid Pain Patch Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Haw Par
6.13.1 Haw Par Corporation Information
6.13.2 Haw Par Non-opioid Pain Patch Description and Business Overview
6.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Haw Par Non-opioid Pain Patch Product Portfolio
6.13.5 Haw Par Recent Developments/Updates
6.14 Nichiban
6.14.1 Nichiban Corporation Information
6.14.2 Nichiban Non-opioid Pain Patch Description and Business Overview
6.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Nichiban Non-opioid Pain Patch Product Portfolio
6.14.5 Nichiban Recent Developments/Updates
6.15 Mentholatum
6.15.1 Mentholatum Corporation Information
6.15.2 Mentholatum Non-opioid Pain Patch Description and Business Overview
6.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Mentholatum Non-opioid Pain Patch Product Portfolio
6.15.5 Mentholatum Recent Developments/Updates
6.16 Laboratoires Genevrier
6.16.1 Laboratoires Genevrier Corporation Information
6.16.2 Laboratoires Genevrier Non-opioid Pain Patch Description and Business Overview
6.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
6.16.5 Laboratoires Genevrier Recent Developments/Updates
6.17 BLUE-EMU
6.17.1 BLUE-EMU Corporation Information
6.17.2 BLUE-EMU Non-opioid Pain Patch Description and Business Overview
6.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.17.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
6.17.5 BLUE-EMU Recent Developments/Updates

7 Non-opioid Pain Patch Manufacturing Cost Analysis
7.1 Non-opioid Pain Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-opioid Pain Patch
7.4 Non-opioid Pain Patch Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-opioid Pain Patch Distributors List
8.3 Non-opioid Pain Patch Customers

9 Non-opioid Pain Patch Market Dynamics
9.1 Non-opioid Pain Patch Industry Trends
9.2 Non-opioid Pain Patch Growth Drivers
9.3 Non-opioid Pain Patch Market Challenges
9.4 Non-opioid Pain Patch Market Restraints

10 Global Market Forecast
10.1 Non-opioid Pain Patch Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-opioid Pain Patch by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Non-opioid Pain Patch by Type (2022-2027)
10.2 Non-opioid Pain Patch Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-opioid Pain Patch by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Non-opioid Pain Patch by Application (2022-2027)
10.3 Non-opioid Pain Patch Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-opioid Pain Patch by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Non-opioid Pain Patch by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Non-opioid Pain Patch Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Non-opioid Pain Patch Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Non-opioid Pain Patch Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Non-opioid Pain Patch Covered in This Study
Table 5. Global Non-opioid Pain Patch Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Non-opioid Pain Patch Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non-opioid Pain Patch Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non-opioid Pain Patch Average Price (USD/K Units) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non-opioid Pain Patch Manufacturing Sites and Area Served
Table 11. Manufacturers Non-opioid Pain Patch Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Pain Patch as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-opioid Pain Patch Sales by Region (2016-2021) & (M Units)
Table 16. Global Non-opioid Pain Patch Sales Market Share by Region (2016-2021)
Table 17. Global Non-opioid Pain Patch Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non-opioid Pain Patch Sales by Country (2016-2021) & (M Units)
Table 19. North America Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 20. North America Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 22. Europe Non-opioid Pain Patch Sales by Country (2016-2021) & (M Units)
Table 23. Europe Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 24. Europe Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non-opioid Pain Patch Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Non-opioid Pain Patch Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non-opioid Pain Patch Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non-opioid Pain Patch Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non-opioid Pain Patch Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 32. Latin America Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non-opioid Pain Patch Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 38. Global Non-opioid Pain Patch Sales (M Units) by Type (2016-2021)
Table 39. Global Non-opioid Pain Patch Sales Market Share by Type (2016-2021)
Table 40. Global Non-opioid Pain Patch Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non-opioid Pain Patch Revenue Share by Type (2016-2021)
Table 42. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2016-2021)
Table 43. Global Non-opioid Pain Patch Sales (M Units) by Application (2016-2021)
Table 44. Global Non-opioid Pain Patch Sales Market Share by Application (2016-2021)
Table 45. Global Non-opioid Pain Patch Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non-opioid Pain Patch Revenue Share by Application (2016-2021)
Table 47. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2016-2021)
Table 48. Hisamitsu Corporation Information
Table 49. Hisamitsu Description and Business Overview
Table 50. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 51. Hisamitsu Non-opioid Pain Patch Product
Table 52. Hisamitsu Recent Developments/Updates
Table 53. Mylan Corporation Information
Table 54. Mylan Description and Business Overview
Table 55. Mylan Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 56. Mylan Non-opioid Pain Patch Product
Table 57. Mylan Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Non-opioid Pain Patch Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Actavis Corporation Information
Table 64. Actavis Description and Business Overview
Table 65. Actavis Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 66. Actavis Non-opioid Pain Patch Product
Table 67. Actavis Recent Developments/Updates
Table 68. Lingrui Corporation Information
Table 69. Lingrui Description and Business Overview
Table 70. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 71. Lingrui Non-opioid Pain Patch Product
Table 72. Lingrui Recent Developments/Updates
Table 73. Teikoku Seiyaku Corporation Information
Table 74. Teikoku Seiyaku Description and Business Overview
Table 75. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 76. Teikoku Seiyaku Non-opioid Pain Patch Product
Table 77. Teikoku Seiyaku Recent Developments/Updates
Table 78. Sanofi Corporation Information
Table 79. Sanofi Description and Business Overview
Table 80. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 81. Sanofi Non-opioid Pain Patch Product
Table 82. Sanofi Recent Developments/Updates
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 86. Novartis Non-opioid Pain Patch Product
Table 87. Novartis Recent Developments/Updates
Table 88. Qizheng Corporation Information
Table 89. Qizheng Description and Business Overview
Table 90. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 91. Qizheng Non-opioid Pain Patch Product
Table 92. Qizheng Recent Developments/Updates
Table 93. Endo Corporation Information
Table 94. Endo Description and Business Overview
Table 95. Endo Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 96. Endo Non-opioid Pain Patch Product
Table 97. Endo Recent Developments/Updates
Table 98. Huarun 999 Corporation Information
Table 99. Huarun 999 Description and Business Overview
Table 100. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 101. Huarun 999 Non-opioid Pain Patch Product
Table 102. Huarun 999 Recent Developments/Updates
Table 103. GSK Corporation Information
Table 104. GSK Description and Business Overview
Table 105. GSK Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 106. GSK Non-opioid Pain Patch Product
Table 107. GSK Recent Developments/Updates
Table 108. Haw Par Corporation Information
Table 109. Haw Par Description and Business Overview
Table 110. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 111. Haw Par Non-opioid Pain Patch Product
Table 112. Haw Par Recent Developments/Updates
Table 113. Nichiban Corporation Information
Table 114. Nichiban Description and Business Overview
Table 115. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 116. Nichiban Non-opioid Pain Patch Product
Table 117. Nichiban Recent Developments/Updates
Table 118. Mentholatum Corporation Information
Table 119. Mentholatum Description and Business Overview
Table 120. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 121. Mentholatum Non-opioid Pain Patch Product
Table 122. Mentholatum Recent Developments/Updates
Table 123. Laboratoires Genevrier Corporation Information
Table 124. Laboratoires Genevrier Description and Business Overview
Table 125. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 126. Laboratoires Genevrier Non-opioid Pain Patch Product
Table 127. Laboratoires Genevrier Recent Developments/Updates
Table 128. BLUE-EMU Corporation Information
Table 129. BLUE-EMU Description and Business Overview
Table 130. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 131. BLUE-EMU Non-opioid Pain Patch Product
Table 132. BLUE-EMU Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Non-opioid Pain Patch Distributors List
Table 136. Non-opioid Pain Patch Customers List
Table 137. Non-opioid Pain Patch Market Trends
Table 138. Non-opioid Pain Patch Growth Drivers
Table 139. Non-opioid Pain Patch Market Challenges
Table 140. Non-opioid Pain Patch Market Restraints
Table 141. Global Non-opioid Pain Patch Sales Forecast by Type (2022-2027) & (M Units)
Table 142. Global Non-opioid Pain Patch Sales Market Share Forecast by Type (2022-2027)
Table 143. Global Non-opioid Pain Patch Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 144. Global Non-opioid Pain Patch Revenue Market Share Forecast by Type (2022-2027)
Table 145. Global Non-opioid Pain Patch Sales Forecast by Application (2022-2027) & (M Units)
Table 146. Global Non-opioid Pain Patch Sales Market Share Forecast by Application (2022-2027)
Table 147. Global Non-opioid Pain Patch Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 148. Global Non-opioid Pain Patch Revenue Market Share Forecast by Application (2022-2027)
Table 149. Global Non-opioid Pain Patch Sales Forecast by Region (2022-2027) & (M Units)
Table 150. Global Non-opioid Pain Patch Sales Market Share Forecast by Region (2022-2027)
Table 151. Global Non-opioid Pain Patch Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 152. Global Non-opioid Pain Patch Revenue Market Share Forecast by Region (2022-2027)
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Pain Patch
Figure 2. Global Non-opioid Pain Patch Market Share by Type in 2020 & 2027
Figure 3. Lidocaine Patches Product Picture
Figure 4. Diclofenac Patches Product Picture
Figure 5. Indomethacin Patches Product Picture
Figure 6. Counter-Irritant Patches Product Picture
Figure 7. Fentanyl Patches Product Picture
Figure 8. Others Product Picture
Figure 9. Global Non-opioid Pain Patch Market Share by Application in 2020 & 2027
Figure 10. OTC
Figure 11. Rx
Figure 12. Global Non-opioid Pain Patch Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Non-opioid Pain Patch Market Size 2016-2027 (US$ Million)
Figure 14. Global Non-opioid Pain Patch Sales 2016-2027 (M Units)
Figure 15. Global Non-opioid Pain Patch Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Non-opioid Pain Patch Sales Share by Manufacturers in 2020
Figure 17. Global Non-opioid Pain Patch Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Non-opioid Pain Patch Players: Market Share by Revenue in 2020
Figure 19. Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Non-opioid Pain Patch Sales Market Share by Region (2016-2021)
Figure 21. Global Non-opioid Pain Patch Sales Market Share by Region in 2020
Figure 22. Global Non-opioid Pain Patch Revenue Market Share by Region (2016-2021)
Figure 23. Global Non-opioid Pain Patch Revenue Market Share by Region in 2020
Figure 24. U.S. Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Non-opioid Pain Patch by Type (2016-2021)
Figure 49. Sales Market Share of Non-opioid Pain Patch by Application (2016-2021)
Figure 50. Sales Market Share of Non-opioid Pain Patch by Application in 2020
Figure 51. Revenue Share of Non-opioid Pain Patch by Application (2016-2021)
Figure 52. Revenue Share of Non-opioid Pain Patch by Application in 2020
Figure 53. Manufacturing Cost Structure of Non-opioid Pain Patch
Figure 54. Manufacturing Process Analysis of Non-opioid Pain Patch
Figure 55. Non-opioid Pain Patch Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock